Responding for rewarding brain stimulation: Cocaine and isradipine plus naltrexone

Pharmacology Biochemistry and Behavior

Volumn 61, Issue 2, 1998, Pages 181-192

  Pabello, Nina G ^a   Hubbell, Christopher L ^a   Cavallaro, Colleen A ^a   Barringer, Tia M ^a   Mendez, Jason J ^a   Reid, Larry D ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Brain stimulation reward; Cocaine; Cocaine abuse; Cocaine dependence; Cocaine treatment; Cocaine use disorders; Fluoxetine; Isradipine; Naltrexone

Indexed keywords

COCAINE; ISRADIPINE; NALTREXONE; PLACEBO;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CALCIUM CHANNEL BLOCKERS; COCAINE-RELATED DISORDERS; DRUG THERAPY, COMBINATION; ELECTRIC STIMULATION; FLUOXETINE; ISRADIPINE; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; VALPROIC ACID;

EID: 0032190274     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00084-7     Document Type: Article

References (59)

1. Bain G.T., Kornetsky C. Opioids' modification of central reward processes. Reid L.D. Opioids, bulimia, and alcohol abuse & alcoholism. 1990;73-87 Springer Verlag, New York.
2. Barringer, T. M.: The effects of desipramine, fluoxetine and naltrexone on cocaines' ability to facilitate pressing for intracranial stimulation. Unpublished Masters' Thesis, Rensselaer Polytechnic Institute, Troy, NY; 1998.
3. Batki S.L., Manfredi L.B., Jacob P. III, Jones R.T. Fluoxetine for cocaine dependence in methadone maintenance. Quantitative plasma and urine cocaine/benzoylecgonine concentrations J. Clin. Psychopharmacol. 13:1993;243-250.
4. Batki S.L., Washburn A.M., Delucchi K., Jones R.T. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 41:1996;137-142.
5. Bilsky E.J., Montegut M.J., Delong C.L., Reid L.D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;PL85-PL90.
6. Bozarth M.A. Methods of assessing the reinforcing properties of abused drugs. 1987;Springer Verlag, New York.
7. Calabrese J.R., Bowden C., Woyshville M.J. Lithium and the anticonvulsants in the treatment of bipolar disorder. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;1109-1112 Raven Press, New York.
8. Calabrese J.R., Rapport D.J., Kimmel S.E., Reece B., Woyshville M.J. Rapid cycling bipolar disorder and its treatment with valproate. Can. J. Psychiatry. 38:1993;S57-S66.
9. Calcagnetti D.J., Keck B.J., Quatrella L.A., Schechter M.D. Blockade of cocaine-induced conditioned place preference. Relevance to cocaine abuse therapeutics Life Sci. 56:1995;475-483.
10. Cramer, C. M.; Gardell, L. R.; Boedeker, K. L.; Harris, J. R.; Hubbell, C. L.; Reid, L. D.: Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharmacol. Biochem. Behav. (in press).
11. Crow T.J. Enhancement by cocaine of intracranial self-stimulation in the rat. Life Sci. 9:1970;375-381.
12. DeMet E.M., Katz M.L., Malekzadeh T. Effects of isradipine on alcohol craving. Soc. Neurosci. Abstr. 23:1997;2393.
13. Esposito R.V., Kornetsky C. Opioids and rewarding brain stimulation. Neurosci. Biobehav. Rev. 2:1978;115-122.
14. Fadda F., Garau B., Columbo G., Gessa G.L. Isradipine and other calcium channel antagonists attenuate alcohol consumption in ethanol-preferring rats. Alcohol. Clin. Exp. Res. 16:1992;449-452.
15. Gardell L.R., Reid L.D., Boedeker K.L., Liakos T.M., Hubbell C.L. Isradipine and isradipine in combination with naltrexone as pharmacotherapy for alcohol dependence. Alcohol. Clin. Exp. Res. 21:1997;1592-1598.
16. Gardell, L. R.; Whalen, C. A.; Chambers, M. D.; Boswell, K. J.; Hubbell, C. L.; Reid, L. D.: Assessing valproate's potential as a medicine for alcohol abuse and alcoholism. Behav. Pharmacol. (submitted).
17. Gardell L.R., Whalen C.A., Chattophadyay S., Cavallaro C.A., Hubbell C.L., Reid L.D. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol. Clin. Exp. Res. 21:1997;1435-1439.
18. Gerrits M.A., Patkina N., Zvartau E.E., van Ree J.M. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology (Berlin). 119:1995;92-98.
19. Gonzales P.M., Boswell K.J., Hubbell C.L., Reid L.D. Isradipine blocks cocaines' ability to facilitate pressing for intracranial stimulation. Pharmacol. Biochem. Behav. 58:1997;1117-1122.
20. Grabowski J., Rhoades H., Elk R., Schmitz J., Davis C., Creson D., Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence. Two placebo-controlled double-blind trials J. Clin. Psychopharmacol. 15:1995;163-174.
21. Herning R.I., Guo X., Lange W.R. Nimodipine improves information processing in substance abusers. Ann. NY Acad. Sci. 765:1995;152-159.
22. Herning R.I., Guo X., Lange W.R. The effects of nimodipine on the EEG of substance abusers. Ann. NY Acad. Sci. 765:1995;143-151.
23. Holman B.L., Carvalho P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., Hebben N., Johnson K.A. Brain perfusion is abnormal in cocaine-dependent polydrug users. A study using Technetium-99m-HMPAO an ASPECT J. Nucl. Med. 32:1991;1206-1210.
24. Houdi A.A., Bardo M.T., Van Loon G.R. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res. 497:1989;195-198.
25. Hubbell C.L., Reid L.D. Antagonism at δ opioid receptors blocks cocaines,' but not morphines,' enhancement of responding for intracranial stimulation. Exp. Clin. Psychopharmacol. 3:1995;123-128.
26. Keesey R.E. Duration of stimulation and reward properties of hypothalamic stimulation. J. Comp. Physiol. Psychol. 58:1964;201-207.
27. Kim H.S., Park W.K., Jang C.G., Oh K.W., Kong J.Y., Oh S., Rheu H.M., Cho D.H., Kang S.Y. Blockade by naloxone of cocaine-induced hyperactivity, reverse tolerance and conditioned place preference in mice. Behav. Brain Res. 85:1997;37-46.
28. Koob G.F., Spector N.H., Meyerhoff J.L. Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat. Psychopharmacologia. 42:1975;231-234.
29. Kornetsky C., Esposito R.U. Euphorigenic drugs. Effects on the reward pathways of the brain Fed. Proc. 38:1979;2473-2476.
30. Kuzmin A.V., Gerrits M.A., van Ree J.M., Zvartau E.E. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci. 60:1997;PL257-PL264.
31. Kuzmin A., Zvartau E., Gessa G.L., Martellotta M.C., Fratta W. Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 41:1992;497-500.
32. Markou A., Hauger R.L., Koob G.F. Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology (Berlin). 109:1992;305-314.
33. Markou A., Koob G.F. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology. 7:1992;213-224.
34. Markou A., Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 4:1991;17-26.
35. Martellotta M.C., Kuzmin A., Muglia P., Gessa G.L., Fratta W. Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology (Berlin). 113:1994;378-380.
36. O'Brien C.P., Volpicelli L.A., Volpicelli J.R. Naltrexone in the treatment of alcoholism. A clinical review Alcohol. 13:1996;35-39.
37. Olds J. Hypothalamic substrates of reward. Physiol. Rev. 42:1962;554-604.
38. Olds M.E., Olds J. Effects of lesions in medial forebrain bundle on self-stimulation behavior. Am. J. Physiol. 217:1969;1253-1264.
39. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry. 49:1992;881-887.
40. Pani L., Kuzmin A., Martellotta M.C., Gessa G.L., Fratta W. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res. Bull. 26:1991;445-447.
41. Pollack M.H., Rosenbaum J. Fluoxetine treatment of cocaine abuse in heroin addicts. J. Clin. Psychiatry. 52:1991;31-33.
42. Post R.M., Weiss S.R.B. The neurobiology of treatment-resistant mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;1155-1170 Raven Press, New York.
43. Pucilowski O., Plaznik A., Overstreet D.H. Isradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat. Neuropsychopharmacology. 12:1995;239-244.
44. Reid L.D. Endogenous opioids and alcohol dependence. Opioid alkaloids and propensity to drink alcoholic beverages Alcohol. 13:1996;5-11.
45. Reid L.D. Tests involving pressing for intracranial stimulation as an early procedure for screening likelihood of addiction of opioids and other drugs. Bozarth M.A. Methods of assessing the reinforcing properties of abused drugs. 1987;391-420 Springer Verlag, New York.
46. Reid L.D., Hubbell C.L., Glick S.D., Boswell K.J., Chen A.M., Moran C.M., Cramer C.M., Mullen U.D., Chambers M.D., Gonzales P.M., Irizarry K.L., Amendola C.A. Initial analyses of naltriben, a delta opioid receptor antagonist, as a putative medicine for treating cocaine abuse. Exp. Clin. Psychopharmacol. 4:1996;271-284.
47. Reid L.D., Hubbell C.L., Tsai J., Fishkin M.D., Amendola C.A. Naltrindole, a δ opioid antagonist, blocks MDMAs' ability to enhance pressing for rewarding brain stimulation. Pharmacol. Biochem. Behav. 53:1996;477-480.
48. Reid L.D., Pabello N.G., Cramer C.M., Hubbell C.L. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life Sci. 60:1997;PL119-PL126.
49. Reid L.D., Siviy S.M. Administration of opiate antagonists reveals endorphinergic involvement in reinforcement processes. Smith J.E., Lane J.D. The neurobiology of opiate reward processes. 1983;257-279 Elsevier/North Holland Biomedical Press, Amsterdam.
50. ++ channel antagonists on alcohol preference in alcohol preferring rats. Alcohol. Clin. Exp. Res. 15:1991;314.
51. Rinder H.M., Ault K.A., Jatlow P.I., Kosten T.R., Smith B.R. Platelet α-granule release in cocaine users. Circulation. 90:1994;1162-1167.
52. Rossi N.A., Reid L.D. Affective states associated with morphine injections. Physiol. Psychol. 4:1976;269-274.
53. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine. Empirical and conceptual problems with the anhedonia hypothesis Neurosci. Biobehav. Rev. 21:1997;341-359.
54. Spivey W.H., Euerle B. Neurologic complications of cocaine abuse. Ann. Emerg. Med. 19:1990;1422-1428.
55. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers. Demonstration by SPECT perfusion brain scintigraphy Radiology. 176:1990;821-824.
56. Volkow N.D., Mullani N., Gould K.L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users. A study with positron emission tomography Br. J. Psychiatry. 152:1988;641-648.
57. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
58. Volpicelli J.R., O'Brien C.P., Alterman A.I., Hayashida M. Naltrexone and the treatment of alcohol dependence. Initial observations Reid L.D. Opioids, bulimia, and alcohol abuse & alcoholism. 1990;195-214 Springer Verlag, New York.
59. Walsh S.L., Preston K.L., Sullivan J.T., Fromme R., Bigelow G. Fluoxetine alters the effects of intravenous cocaine in humans. J. Clin. Psychopharmacol. 4:1994;396-407.